Cara Therapeutics (CARA) shares tumbled 22% in recent Friday premarket activity, shaving Thursday's surge.
Novo Nordisk (NVO) stock slumped 20% after it said its experimental obesity therapy CagriSema met the primary endpoint in a phase 3 trial as it showed superior weight loss compared to a placebo, but the results fell short of its expectations.
NIKE (NKE) stock was down 7.2%, a day after it reported lower fiscal Q2 earnings and revenue from a year earlier.
United States Steel (X) shares slipped 6%, after saying Thursday it expects a Q4 adjusted net loss per diluted share between $0.29 and $0.25. Analysts polled by FactSet expect non-GAAP earnings per share of $0.04.
Tesla (TSLA) stock fell almost 5% after the National Highway Traffic Safety Administration said Thursday that the EV maker is recalling 694,304 vehicles in the US over a problem with the tire pressure monitoring system.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。